Evidence map›Paper›PMID 29995279›Full record

ReviewCurrent nutrition reports2018

Stevia rebaudiana Bertoni and Its Effects in Human Disease: Emphasizing Its Role in Inflammation, Atherosclerosis and Metabolic Syndrome.

Edward Rojas, Valmore Bermúdez, Yasaman Motlaghzadeh, Justin Mathew, Enzamaria Fidilio, Judith Faria, Joselyn Rojas, Mayela Cabrera de Bravo, Julio Contreras, Linda Pamela Mantilla and 3 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current nutrition reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Frontiers in pharmacology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Contemporary Trends and Habits in the Consumption of Sugar and Sweeteners-A Questionnaire Survey among Poles.International journal of environmental research and public health · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 5 countries.

Edward RojasDepartment of Medicine, Rutgers University, 150 Bergen St, Newark, NJ, 07101, USA. er520@njms.rutgers.edu.
Valmore BermúdezEndocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo, Venezuela.
Yasaman MotlaghzadehDepartment of Medicine, Rutgers University, 150 Bergen St, Newark, NJ, 07101, USA.
Justin MathewDepartment of Medicine, Rutgers University, 150 Bergen St, Newark, NJ, 07101, USA.
Enzamaria FidilioEndocrinology and Nutrition Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Judith FariaDepartment of Medicine, St. Michael's Medical Center, Newark, New Jersey, USA.
Joselyn RojasDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Mayela Cabrera de BravoBiology Department, Lone Star College, Tomball, TX, USA.
Julio ContrerasInvestigation Group High Studies of Frontier, Simón Bolívar University, Barranquilla, Colombia.
Linda Pamela MantillaInvestigation Group High Studies of Frontier, Simón Bolívar University, Barranquilla, Colombia.
Lissé AngaritaNutrition School of Andres Bello University, Concepcion, Chile.
Paola Amar SepúlvedaInvestigation Group for Innovations and Entrepreneurship, Simon Bolivar University, Barranquilla, Colombia.
Isaac KuzmarFaculty of Health Sciences, Research, Innovation and Development Department, Simón Bolívar University, Barranquilla, Colombia.
Universidad Simón Bolívar · CORutgers, The State University of New Jersey · USBrigham and Women's Hospital · USLone Star College–Tomball · USSaint Michael's Medical Center · USUniversidad Andrés Bello · CLUniversity of Zulia · VEVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewStevia rebaudiana Bertoni is a perennial shrub with zero calorie content that has been increasing in popularity for its potential use as an adjuvant in the treatment of obesity. The level of evidence supporting general benefits to human health is insufficient. We conducted a review of the literature summarizing the current knowledge and role in human disease. RECENT

findingsDespite stevia's minimal systemic absorption, studies have been promising regarding its potential benefits against inflammation, carcinogenesis, atherosclerosis glucose control, and hypertension. On the other hand, the growing popularity of artificial sweeteners does not correlate with improved trends in obesity. An increased intake of artificial non-caloric sweeteners may not be associated with decreased intake of traditional sugar-sweetened beverages and foods. The effects of Stevia on weight change have been linked to bacteria in the intestinal microbiome, mainly by affecting Clostridium and Bacteroides sp. POPULATIONS: A growing body of evidence indicates that Stevia rebaudiana Bertoni is protective against malignant conversion by inhibition of DNA replication in human cancer cell growth in vitro. Consumption of Stevia has demonstrated to be generally safe in most reports. Further clinical studies are warranted to determine if regular consumption brings sustained benefits for human health.

Indexed as

HypertensionObesityStevia rebaudiana BertoniType 2 diabetes

Identifiers

PMID29995279
OpenAlexW2867283588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.